CD9 and Cirrhosis: Additionally, the scar-associated macrophages (SAMs) differentiated by markers such as TREM2, CD9, SPP1, TNFSF12, and LGALS3 and PDGFRA+ myofibroblasts had an increased proportion in patients with cirrhosis (Figure 3B).